Efficacy and pharmacokinetics of a modified acid-labile docetaxel-PRINT(®) nanoparticle formulation against non-small-cell lung cancer brain metastases.
about
Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38.Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer.Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.
P2860
Efficacy and pharmacokinetics of a modified acid-labile docetaxel-PRINT(®) nanoparticle formulation against non-small-cell lung cancer brain metastases.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Efficacy and pharmacokinetics ...... lung cancer brain metastases.
@en
type
label
Efficacy and pharmacokinetics ...... lung cancer brain metastases.
@en
prefLabel
Efficacy and pharmacokinetics ...... lung cancer brain metastases.
@en
P2093
P2860
P356
P1433
P1476
Efficacy and pharmacokinetics ...... lung cancer brain metastases.
@en
P2093
Allison Deal
Allison Schorzman
Amanda Van Swearingen
Carey K Anders
Charles Bowerman
J Christopher Luft
Joseph DeSimone
Maria Sambade
Olga Karginova
P2860
P304
P356
10.2217/NNM-2016-0147
P577
2016-07-26T00:00:00Z